Stephen Brunton, MD, Director of Faculty Development, Cabarrus Family Medicine, Charlotte, North Carolina, discusses the most recent U.S. Preventive Services Task Force (USPSTF) recommendations about screening sexually active adolescents and adults for chlamydial infection.

References
U.S. Preventive Services Task Force. Screening for chlamydial infection: U.S. Preventive Services Task Force recommendation statement.
Ann Intern Med. 2007 Jul 17;147(2):128-34. Epub 2007 Jun 18
Click Here to read the article.

Click Here to download the summary of the guidelines

The Task Force grades the strength of the evidence from “A” (strongly recommends), “B” (recommends), “C” (no recommendation for or against), “D” (recommends against), or “I” (insufficient evidence to recommend for or against).
Click Here to view the what the U.S. Preventive Services Task Force grades mean and suggestions for practice.

Dr. Brunton has disclosed the following:
Consulting Fees: Pfizer, Novo Nordisk, Amylin, Takeda, Novartis

Sponsored by The Doctor’s Channel